SEC Form 4 · accession 0001776004-26-000003
Adicet Bio, Inc. · ACET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lloyd Klickstein
Officer — Chief Medical Officer · Director
Period of report
Aug 5, 2026
Accepted (ET)
Aug 7, 2026 · 4:01 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001720580
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $9.16 | Aug 5, 2026 | A | 18,300 | A | — | Aug 4, 2036 | Common Stock | 18,300 | 18,300 | D |
Explanation of responses
- F11/6th of the shares subject to this option shall vest and become exercisable on each of the next six (6) monthly anniversaries of August 5, 2026, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting dates.